Back

Deciphering the effect of exercise timing on glucose metabolism: a randomised controlled trial

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Managing diabetes and glucose metabolism Public Health EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Ms Fabienne Bruggisser

Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Proteomic screening using NGS-based method identifies cardiovascular diseases biomarkers in patients without cardiovascular disease but with glucose metabolism disturbances.
Professor K. Kaminski (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Exploring the preventive role of GLP-1 receptor agonists in reducing pulmonary hypertension in diabetes: a multimodal analysis
Doctor A. Albulushi (Muscat, OM)
Abstract Slides
Presentation thumbnail
Effect of SGLT2 inhibitors on temporal change of skeletal muscle index in patients with outpatient cardiac rehabilitation program
Doctor M. Kanazawa (Morioka, JP)
Abstract Slides
Presentation thumbnail
Application and usability of telemonitoring devices and Apps for patients with heart failure and diabetes type II.
Doctor S. Scalvini (Lumezzane, IT)
Abstract Slides
Presentation thumbnail
Non-invasive continuous glucose monitoring in patients without diabetes: use in cardiovascular prevention - a systematic review
Ms G. Petrasch (Davos Wolfgang, CH)
Abstract Slides

Access the full session

Session thumbnail
Managing diabetes and glucose metabolism

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025
You may be interested in
thumbnail
Congress Presentation
Real-world evaluation of an algorithmic machine-learning-guided testing approach in stable chest pain: a multinational, multicohort study
thumbnail
Congress Presentation
The cost-effectiveness of a digitally enabled telerehabilitation program delivered nationally to patients in Australia
thumbnail
Congress Presentation
EHRs and Omics for disease phenotypin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources